Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
McKinsey
Citi
Covington
Fish and Richardson
Farmers Insurance
Federal Trade Commission
Julphar
Chubb

Generated: January 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Rebastinib

« Back to Dashboard

US Patents for Rebastinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Rebastinib ➤ Try a Free Trial Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases Deciphera Pharmaceuticals, LLC (Lawrence, KS) ➤ Try a Free Trial
Rebastinib ➤ Try a Free Trial Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases Deciphera Pharmaceuticals, LLC (Lawrence, KS) ➤ Try a Free Trial
Rebastinib ➤ Try a Free Trial Methods for inhibiting tie-2 kinase useful in the treatment of cancer Deciphera Pharmaceuticals, LLC (Lawrence, KS) ➤ Try a Free Trial
Rebastinib ➤ Try a Free Trial Proteolysis targeting chimera compounds and methods of preparing and using same Yale University (New Haven, CT) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Rebastinib

Drugname Country Document Number Estimated Expiration Related US Patent
Rebastinib Australia 2007307679 2026-10-11 ➤ Try a Free Trial
Rebastinib Brazil PI0719195 2026-10-11 ➤ Try a Free Trial
Rebastinib Canada 2666563 2026-10-11 ➤ Try a Free Trial
Rebastinib China 101553233 2026-10-11 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
UBS
Cerilliant
Federal Trade Commission
McKinsey
Johnson and Johnson
Dow
US Department of Justice
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.